We are live on ! Find out more
NEXI

NexImmune, Inc. Common Stock

Delisted

NEXI was delisted on the 11th of July, 2024.

47 hedge funds and large institutions have $160M invested in NexImmune, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 20 increasing their positions, 8 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 8

71% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 7

35% more capital invested

Capital invested by funds: $118M → $160M (+$42M)

12% more funds holding

Funds holding: 4247 (+5)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
47
Holders Change
+5
Holders Change %
+11.9%
% of All Funds
0.82%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
12
Increased
20
Reduced
8
Closed
7
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Russell Investments Group
51
Russell Investments Group
United Kingdom
-$39K -97 Closed
UBS Group
52
UBS Group
Switzerland
-$18K -43 Closed
SOW
53
State of Wyoming
Wyoming
-$13K -31 Closed
S
54
SignatureFD
Georgia
+$335 +1 New

NEXI Hedge Fund Activity: Q3 2021 in Review

47 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in NexImmune, Inc. Common Stock (NEXI) for Q3 2021, worth a combined $160M — up 35% from $118M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new NEXI positions and 7 closed out — a net gain of 5 holders — while 20 added to existing stakes and 8 trimmed.

The largest buyer was BlackRock, adding an estimated $6.55M. The largest seller was ArrowMark Colorado Holdings, cutting an estimated $7.9M.

  • 47 institutional investors held NexImmune, Inc. Common Stock (NEXI) as of Q3 2021, up from 42 in Q2 2021.
  • Funds reported $160M of NexImmune, Inc. Common Stock stock for Q3 2021, up 35% quarter-over-quarter.
  • 12 funds opened new NexImmune, Inc. Common Stock positions in Q3 2021 and 7 closed out, a net change of +5 holders.
  • The largest NexImmune, Inc. Common Stock buyer in Q3 2021 was BlackRock, an estimated $6.55M added.
  • The largest NexImmune, Inc. Common Stock seller in Q3 2021 was ArrowMark Colorado Holdings, an estimated $7.9M sold.

Based on aggregated 13F filings for Q3 2021.